Omda AS
The answer first
Does Omda beat the market?
No, Omda has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 19% of Nordic stocks
- Quality4
- Value13
- Trend87
No. 131 of 195 in healthcare
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash Omda keeps must grow about 18% a year for 10 years.
Max for seven days
Follow Omda with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Omda
Your first answer is free, no account needed.
Do you own Omda, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Omda and a few more. Free, no card.
Super Stock+45.9%In short
- Omda has fallen 5.0% over the past year, including dividends.
- Overall, Omda ranks better than 19% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 77.8%. The price is 56.5% below its peak now.
What do analysts think of Omda?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 19% of Nordic stocks.
No. 131 of 195 in healthcare
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 193 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity−24.24
- Asset turnoverSales divided by everything the company owns0.69
- Return on equityProfit divided by equity−158.8%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 123 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50
- P/BPrice divided by equitynegative earnings
- P/SPrice divided by sales1.9
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flow16.6
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 30 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+24.4%
- 6 months+30.5%
- 9 months+9.8%
- 12 months−5.0%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Omda
Omda AS is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 250 employees.
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution.


See the full analysis of Omda.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card